Enable your JavaScript to use Numstock


Numstock » ABIO

ABIO Stock Analysis

The latest metrics for ARCA biopharma, Inc

Value

Metric Target Value
Price / Earnings Ratio < 12.0 -0.78
Price / Book Value Ratio < 1.5 0.94
Price / Sales Ratio < 2.0 0.0
PEG Ratio < 1.0 0.0
EV / EBITDA Ratio < 8.0 0.25
Price / FCF Ratio Last Year < 15.0 -0.64
Price / FCF Ratio Last Quarter < 15.0 -8.31
Price / TBV Ratio Last Year < 0.7 0.86
Price / TBV Ratio Last Quarter < 0.7 1.18
Price / NCAV Ratio Last Year < 0.7 0.87
Price / NCAV Ratio Last Quarter < 0.7 1.19

Efficiency

Metric Target Value
ROE Last Year > 25.0% -97.3
ROE Last Quarter > 25.0% -12.85
ROA Last Year > 15.0% -116.2
ROA Last Quarter > 15.0% -11.62
ROTA Last Year > 20.0% -81.6
ROTA Last Quarter > 20.0% -12.53
ROIC Last Year > 20.0% 1113
ROIC Last Quarter > 20.0% 116.4
ROCE Last Year > 20.0% -134.6
ROCE Last Quarter > 20.0% -13.62
Inventory Turnover Last Year > 4.0 0.0
Inventory Turnover Last Quarter > 4.0 0.0
Pre-tax Margin Last Year > 20.0% 0.0
Pre-tax Margin Last Quarter > 20.0% 0.0
Accounts Payable Turnover Last Year > 3.0 0.0
Accounts Payable Turnover Last Quarter > 3.0 0.0
Accounts Receivable Turnover Last Year > 5.0 0.0
Accounts Receivable Turnover Last Quarter > 5.0 0.0

Health

Metric Target Value
Current Ratio Last Year > 1.5 8.55
Current Ratio Last Quarter > 1.5 12.49
Quick Ratio Last Year > 1.5 8.55
Quick Ratio Last Quarter > 1.5 12.49
Flow Ratio Last Year < 1.25 0.21
Flow Ratio Last Quarter < 1.25 0.33
Debt / Equity Ratio Last Year < 0.5 0.0
Debt / Equity Ratio Last Quarter < 0.5 0.0
Debt / EBITDA Ratio Last Year < 4.0 0.0
Debt / EBITDA Ratio Last Quarter < 4.0 0.0
Debt / NCAV Ratio Last Year < 2.0 0.0
Debt / NCAV Ratio Last Quarter < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Year < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Quarter < 2.0 0.0
Interest Coverage Ratio Ratio Last Year > 8.0 1015
Interest Coverage Ratio Last Quarter > 8.0 1247
FCF / Sales Ratio Last Year > 8.0% 0.0
FCF / Sales Ratio Last Quarter > 8.0% 0.0

Growth

Metric Target Value
Earnings Yield > 12% -128.5
Ebit Yield Last Year > 12% -330.2
Ebit Yield Last Quarter > 12% 562.3
FCF Yield Last Year > 10% -99.7
FCF Yield Last Quarter > 10% -10.75
Forward P/E to Trailing P/E Ratio > 1.1 0.0
Operating Cash Flow / EPS Ratio Last Year > 1.2 1.24
Operating Cash Flow / EPS Ratio Last Quarter > 1.2 0.07

Dividends

Metric Target Value
Dividend Yield > 2.0% 0.0
FCF / Dividends Paid Ratio Last Year > 2.5 0.0
FCF / Dividends Paid Ratio Last Quarter > 2.5 0.0
EPS / Dividends Paid Last Year > 2.5 0.0
EPS / Dividends Paid Last Quarter > 2.5 0.0
Payout Ratio < 40.0% 0.0

Ratings

Metric Target Value
Altman Z-score Last Year ≥ 3.5 -30.92
Altman Z-score Last Quarter ≥ 3.5 -18.84